Press release
Prostate Cancer Diagnostics Market Research Reveals Path To $9.19 Billion By 2030
Prostate Cancer Diagnostics Market
Projected Market Size and Growth Trajectory of the Prostate Cancer Diagnostics Market
The prostate cancer diagnostics market is poised for rapid growth in the coming years, expected to reach a valuation of $9.19 billion by 2030. This expansion corresponds to a robust compound annual growth rate (CAGR) of 12.9%. Several factors contribute to this upward trend, such as advancements in molecular and genomic diagnostic technologies, widespread adoption of precision oncology, increased population screening programs, amplified investment in diagnostic automation, and a rising demand for personalized cancer testing. Key developments anticipated during this period include greater use of sophisticated diagnostic assays, biomarker-driven prostate cancer tests, AI-driven imaging analyses, broader early detection initiatives, and enhanced emphasis on diagnostic precision and risk assessment.
The prostate cancer diagnostics market size has grown rapidly in recent years. It will grow from $5.02 billion in 2025 to $5.66 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to rising prevalence of prostate cancer, expansion of clinical diagnostic infrastructure, increased use of PSA and biopsy testing, availability of imaging-based diagnostic tools, growing awareness of early cancer detection.
Download a free sample of the prostate cancer diagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12003&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Leading Corporations Driving Innovation in the Prostate Cancer Diagnostics Market
The competitive landscape of prostate cancer diagnostics features several influential companies, including F Hoffmann La Roche AG, Bayer AG, Thermo Fisher Scientific Inc, Abbott Laboratories Inc, Siemens Healthineers AG, Becton dic*kinson and Company, Agilent Technologies Inc, Hologic Inc, bioMerieux SA, Beckman Coulter Inc, Qiagen NV, Exact Sciences Corporation, DiaSorin SpA, OPKO Health Inc, Myriad Genetics Inc, Cepheid Inc, NeoGenomics Laboratories Inc, Fujirebio Diagnostics Inc, Ambry Genetics Corporation, MDxHealth SA, Exosome Diagnostics Inc, Cellanyx Diagnostics Inc, A3P Biomedical AB, Roche Diagnostics GmbH, and Sysmex Corporation.
A notable recent development occurred in October 2024 when Trinity Biotech plc, based in Ireland, acquired Epicapture Limited. This strategic move allowed Trinity Biotech to enter the oncology diagnostics arena by incorporating Epicapture's non-invasive epigenetic prostate cancer monitoring test into its offerings. Epicapture specializes in a urine-based DNA methylation assay designed to evaluate the risk of aggressive prostate cancer, reflecting innovation in risk assessment methods.
Emerging Trends Highlighting Technological Progress in Prostate Cancer Diagnostics
Leading market players are focusing on integrating cutting-edge AI technologies to enhance diagnostic accuracy and speed in prostate cancer detection. AI-powered tools employ machine learning to identify prostate adenocarcinoma regions and analyze whole slide images from prostate biopsies, aiding pathologists in making faster and more precise diagnoses.
For instance, in March 2023, Singapore-based company Qritive introduced QAi Prostate, an advanced AI-driven diagnostic solution tailored for pathologists. This tool streamlines workflow, sharpens diagnostic accuracy, and reduces the time needed for treatment preparation, exemplifying the growing role of AI in transforming prostate cancer diagnostics.
View the full prostate cancer diagnostics market report:
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Detailed Segmentation of the Prostate Cancer Diagnostics Market
The global prostate cancer diagnostics market is categorized into multiple segments to cover the full scope of products and services:
1) Product Types: Instruments, Reagents and Consumables, Accessories
2) Test Types: Preliminary Tests, Confirmatory Tests
3) Prostate Cancer Types: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma
4) Patient Groups: Adult, Geriatrics
5) End Users: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End-Users
Further subcategories include:
- Instruments such as biopsy tools, imaging devices, and digital rectal examination equipment
- Reagents and consumables including diagnostic assay kits, staining reagents, and sample collection materials
- Accessories like biopsy guides, specimen handling tools, and equipment calibration and maintenance devices
This comprehensive segmentation allows for detailed analysis of market demands and technological applications across different facets of prostate cancer diagnostics.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prostate Cancer Diagnostics Market Research Reveals Path To $9.19 Billion By 2030 here
News-ID: 4613812 • Views: …
More Releases from The Business Research Company
Presbyopia Market Report Examines Industry Trends, Growth Drivers And Future Out …
The presbyopia market is on track for significant expansion as advancements in vision correction continue to gain momentum. With aging populations and increasing awareness about eye health, this sector is attracting considerable attention from both healthcare providers and technology innovators. Let's explore the current market size, influential players, emerging trends, and the key segments driving growth in the presbyopia industry.
Projected Market Value and Growth in the Presbyopia Sector
Forecasts…
Progressive Multifocal Leukoencephalopathy Treatment Market Demonstrates Long-Te …
Understanding the future outlook of treatments for progressive multifocal leukoencephalopathy (PML) reveals promising growth fueled by advances in medical research and diagnostics. This analysis provides a detailed look into the market size, key players, segmentation, and the factors driving expansion within this specialized therapeutic area.
Projected Market Size of the Progressive Multifocal Leukoencephalopathy Treatment Market by 2030
The market for progressive multifocal leukoencephalopathy treatment is anticipated to expand significantly, reaching…
Primary Immunodeficiency Disorders Market Report 2026 Market Outlook Supported B …
Understanding the future trajectory of the primary immunodeficiency disorders market is crucial for stakeholders and healthcare professionals alike. This sector is experiencing significant advancements driven by innovative therapies and diagnostic improvements, positioning it for substantial growth in the coming years. Here is an in-depth look at market size projections, influential players, prominent trends, and key segmentation insights.
Projected Expansion of the Primary Immunodeficiency Disorders Market by 2030
The market for…
Primary Care POC Diagnostics Market Insights Highlight Segment Expansion And Mar …
The primary care point-of-care (POC) diagnostics market is poised for substantial expansion as healthcare continues to evolve toward more accessible and efficient testing solutions. With advancements in technology and growing demand for rapid diagnostics, this sector is set to play an increasingly vital role in patient care over the coming years. Below is an in-depth look at the market's size, influential players, emerging trends, and segmentation details.
Steady Growth Forecast for…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
